Procedures & recovery · patient guide

How is eczema treated in China?

Eczema care in China follows the same clinical principles used internationally: identifying the type of dermatitis, restoring the skin barrier with emollients, controlling inflammation with topical or sometimes systemic treatment, and addressing triggers and infection. A Chinese dermatologist assesses severity and history before choosing a plan. Overseas patients should confirm the hospital, language support and follow-up arrangements before travelling.

Go to the practical guidance ↓
AI illustration: Two women in a consultation setting, one reviewing documents in a folder.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What a Chinese dermatologist actually assesses first

Eczema is a descriptive term rather than one disease. Atopic dermatitis, contact dermatitis, seborrhoeic dermatitis, nummular eczema and hand eczema behave differently and respond to different measures. The first useful step in any consultation is therefore diagnostic clarity, not a prescription. A dermatologist looks at the distribution and appearance of the rash, asks when it began, what makes it worse, what has already been tried and how it responded, and considers whether another condition is mimicking eczema.

The history matters as much as the examination. Age of onset, family history of atopy, occupation and hobbies, exposure to soaps, solvents, metals or cosmetics, sleep disturbance and itch intensity all shape the plan. So does the patient's own treatment history: which topical steroids or calcineurin inhibitors were used, at what potency, on which body sites, for how long and with what result. Vague statements such as 'steroid cream did not work' are less useful than the actual product name and how it was applied.

For an overseas patient, this assessment is the point at which a China trip either makes sense or does not. If the diagnosis is already clear and the skin is well controlled, a long journey adds little. If the eczema is severe, atypical, repeatedly infected, poorly responsive or complicated by suspected contact allergy, a specialist assessment has more to offer. The treating dermatologist, not a coordinator, decides whether the case fits their clinic and what tests are appropriate.

The core treatments and why they are chosen in a particular order

Most eczema management rests on a small number of well-established elements. Emollients are used regularly to repair the skin barrier and reduce dryness and itch; they are not a cure but they reduce the need for anti-inflammatory treatment. Topical corticosteroids remain the mainstay for inflamed flares, with potency matched to the body site and the severity of the flare. Topical calcineurin inhibitors are another option, particularly for sensitive areas such as the face and eyelids, and for some patients who cannot use steroids.

When topical treatment is insufficient, clinicians consider other routes. Phototherapy uses controlled ultraviolet light for widespread or persistent disease. Systemic treatments, including conventional oral medicines and newer targeted therapies, are reserved for moderate-to-severe disease that has not responded to adequate topical care. Antihistamines may help with sleep or associated itch but do not treat the underlying inflammation. Antibiotics are relevant only when bacterial infection is present, not for eczema itself.

The order is not arbitrary. A clinician generally confirms that the basics have been done properly before escalating: enough emollient, correct steroid potency, correct application, treated infection and removed triggers. Overseas patients sometimes arrive having already tried many products without a clear record of what was used. Reconstructing that history helps the dermatologist avoid repeating what failed and avoid escalating unnecessarily. Any decision to start, stop or change a medicine belongs to the treating clinician, and patients should not alter prescribed treatment on the basis of general information.

Records that make an overseas consultation more useful

A dermatology consultation is largely visual and historical, so the records that help most are the ones that show the skin over time and document what has been tried. Photographs taken in consistent light, including close views of affected areas and wider views showing distribution, are often more informative than a single image taken on the day of travel. A short written summary of the timeline is also valuable.

Patients should gather the names and strengths of topical treatments used, the duration and frequency of use, and the response. For oral medicines, the drug name, dose, dates and reason for stopping are relevant. Patch testing results, biopsy reports and any allergy testing should be included if they exist. A list of current medicines, including over-the-counter products and supplements, helps the clinician avoid interactions.

It is reasonable to ask the receiving hospital what it wants before travelling and in what format, including whether translated summaries are needed and how images should be sent. Do not send a full medical archive or identity documents at the first contact; a brief summary of the problem and the main question is enough to begin. The hospital, not the coordinator, determines what is clinically necessary.

Practical questions to settle before booking care in China

The clinical plan is only part of the decision. Overseas patients also need to know how the visit will work in practice. Which hospital and department will see the patient, and is the dermatology service experienced with the specific pattern of disease? Is interpretation available during the consultation, and who provides it? Will the assessment be completed in one visit or will the clinician need to review results later, and how would that review happen if the patient has returned home?

Follow-up is a genuine planning issue for a chronic skin condition. Eczema management often involves adjusting treatment over time rather than a single decisive intervention. Patients should ask how repeat prescriptions, dose adjustments and flare management would be handled from abroad, and whether the treating team is willing to support shared care with the patient's local doctor. The answers vary by hospital and clinician, so they should be confirmed rather than assumed.

Cost questions should be directed to the specific provider. Hospital consultation, tests, medicines and any procedures are charged by the hospital, while coordination or interpretation services are separate. Ask for a written outline of what a quoted fee covers and what is billed separately. General figures from other countries or other hospitals do not establish what a particular Chinese hospital will charge for this patient.

Safety boundaries and what general guidance cannot decide

Eczema is usually manageable but not always simple. Worsening redness, pain, weeping, crusting or fever can indicate infection and needs prompt assessment by a clinician, locally if travel is not imminent. Severe or rapidly spreading rash, breathing difficulty or facial swelling requires urgent care. These situations take priority over planning an overseas appointment.

General information cannot determine which potency of steroid is right for a given body site, whether a flare is infected, whether a systemic treatment is suitable, or whether a child's eczema needs a different approach. Those decisions depend on examination and history. Patients who have been prescribed treatment should continue it as directed unless their own clinician advises otherwise, and should not stop medicines in preparation for a trip without medical advice.

It is also reasonable to ask the treating dermatologist about the expected course of treatment, the alternatives, and the risks and benefits in this individual case. A clinician can discuss evidence-based expectations without guaranteeing an individual outcome. Patients should be cautious about any source that promises a cure or a fixed result.

A realistic next step

For an overseas patient considering eczema care in China, the practical first step is to clarify the diagnosis and the question that remains unanswered, then gather a concise history, treatment record and good photographs. A short initial enquiry describing the problem and the main question is free and does not commit the patient to anything. It helps identify what information is missing and which type of specialist or hospital might be relevant.

From there, the patient can decide whether a records-based opinion or an in-person appointment is worth pursuing. Hospital acceptance and the clinical plan remain decisions for the treating team. ChinaSpecialistCare can help with information and non-clinical coordination, but it does not diagnose, prescribe or decide suitability. Patients should confirm the hospital, clinician, language arrangements and fee scope in writing before making travel commitments.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. procedures
  2. National Institute for Health and Care Excellence: Atopic eczema in under 12s: diagnosis and management
  3. National Eczema Association: Eczema treatments

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.